TD Waterhouse Canada’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-33
| Closed | -$3.36K | – | 1822 |
|
2023
Q2 | $3.36K | Hold |
33
| – | – | ﹤0.01% | 1458 |
|
2023
Q1 | $3.1K | Hold |
33
| – | – | ﹤0.01% | 1457 |
|
2022
Q4 | $1.21K | Hold |
33
| – | – | ﹤0.01% | 1543 |
|
2022
Q3 | $855 | Hold |
33
| – | – | ﹤0.01% | 1589 |
|
2022
Q2 | $1.01K | Hold |
33
| – | – | ﹤0.01% | 1619 |
|
2022
Q1 | $1.17K | Buy |
+33
| New | +$1.17K | ﹤0.01% | 1658 |
|